Bispecific Playgrounds? No, Factory Floors
Developers Prepare for Future Biologics Work by Exploring a Multitude of Antibody Formats
GEN Roundup: Multiplexed Immunoassays: Small Samples, Big Pictures
Taking in "Everything All at Once" Can Reveal Meaningful Biological Patterns and Drug Targets
Bioprocessing Companies Push Limits of Upstream Technologies
Goal Is to Maximize Efficiency in Bioprocess Operations
In the mAb Race, Don’t Stumble at Characterization
Researchers Adapt Existing Techniques to Deal with Challenging New Monoclonal Antibodies
For full access to this article login to GEN Select now.
RNAi Efforts Ready to Pay Dividends
Recounting the Journey from Biological Oddity to a Commercialized Technology
- In the fall of 2006, the RNA world arrived on the big stage when it was announced that Andrew Z. Fire, Ph.D., Craig Mello, Ph.D., and Roger Kornberg, Ph.D., were selected to receive the Nobel Prizes in Physiology or Medicine (Drs. Fire and Mellow) and Chemistry (Dr. Kornberg) for ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.